Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis

被引：0
|
作者：
Cooper, C
Reginster, JY
McClung, M
Zorich, NL
Li, Z
机构：
[1] Univ Southampton, Southampton, Hants, England
[2] Univ Liege, Liege, Belgium
[3] Oregon Osteoporosis Ctr, Portland, OR USA
[4] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [21] Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women
    M. Osaki
    K. Tatsuki
    T. Hashikawa
    T. Norimatsu
    K. Chiba
    S. Motokawa
    I. Furuichi
    Y. Doiguchi
    K. Aoyagi
    H. Shindo
    Osteoporosis International, 2012, 23 : 695 - 703
  • [22] EDITOR RESPONSE: RETRACTION: RISEDRONATE THERAPY FOR PREVENTION OF HIP FRACTURE AFTER STROKE IN ELDERLY WOMEN; RISEDRONATE THERAPY FOR PREVENTION OF HIP FRACTURE AFTER STROKE IN ELDERLY WOMEN: REPLY FROM THE AUTHORS
    Gross, Robert A.
    Griggs, Robert C.
    NEUROLOGY, 2017, 88 (02) : 221 - 221
  • [23] Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis
    Seeman, E
    Vellas, B
    Benhamou, CL
    Aquino, JP
    Semler, J
    Kaufman, JM
    Hoszowski, K
    Varela, AR
    Fiore, CE
    Brixen, K
    Reginster, JY
    Boonen, S
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 953 - 953
  • [24] Risk factors for hip fracture in elderly women
    Haentjens, P
    Autier, P
    Boonen, S
    Bentin, J
    Baillon, JM
    Grivegnée, AR
    SIROT 99, 1999, : 221 - 225
  • [25] Osteoporosis: High Risk of Hip Fracture in older Women
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (22) : 1543 - 1544
  • [26] Sustained fracture risk reduction over 5 years with risedronate therapy.
    Watts, NB
    Brown, J
    Hosking, D
    Adami, S
    Mulder, H
    Reginster, JY
    Kasibhatla, C
    Chines, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S217 - S217
  • [27] Vertebral fracture risk reduction with risedronate in postmenopausal women with osteoporosis: A meta-analysis of individual patient data
    Adachi, JD
    Li, Z
    Meredith, M
    Chesnut, CH
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S61 - S61
  • [28] Risedronate at both 2.5 mg and 5.0 mg daily doses reduces the risk of hip fracture in women with established osteoporosis
    McClung, Michael R.
    Purple, Christopher R.
    Zhou, Xiaojie
    Watts, Nelson
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S215 - S215
  • [29] Risedronate rapidly reduces vertebral fracture risk in postmenopausal women with established osteoporosis
    Roux, C
    Miller, P
    Gennari, C
    Keller, M
    Sorensen, O
    Ritter-Hrncirik, C
    Barton, I
    Watts, N
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S287 - S287
  • [30] CLEAR AND RAPID FRACTURE REDUCTION UNDER RISEDRONATE
    不详
    JOURNAL FUR MINERALSTOFFWECHSEL, 2007, 14 (02): : 84 - 84
12345